ArticleDiabetology & metabolic syndrome2025
Relationship between stress hyperglycemia ratio and the incidence of atrial fibrillation in patients after coronary artery bypass grafting: a retrospective study based on the MIMIC-IV database.
Article in Diabetology & metabolic syndrome, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Stress hyperglycemia ratio in coronary artery disease: a systematic review and meta-analysis of severity and prognosis.Cardiovascular diabetology · 2026Pooled it
- Prognostic value of stress hyperglycemia ratio, hemoglobin glycation index, and glycemic variability for postoperative atrial fibrillation: a machine learning-based prediction model.BMC medical informatics and decision making · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundThe stress hyperglycemia ratio (SHR) is a clinical index that quantifies acute stress-induced hyperglycemia by comparing immediate blood glucose levels with chronic glucose control (reflected by HbA1c). It is especially valuable in cardiovascular disease and surgical prognosis. However, there is still a lack of research on the relationship between SHR and new-onset atrial fibrillation (AF) in patients after coronary artery bypass grafting (CABG). This study investigates the impact of postoperative SHR on AF risk following CABG.
methodsThis study is a retrospective cohort analysis conducted through the MIMIC-IV database, which included adult patients who underwent CABG and were admitted to the ICU. These patients were categorized into three distinct groups according to the tertiles of the baseline SHR level, and the primary outcome was the incidence of postoperative atrial fibrillation (POAF). We employed logistic regression models, restricted cubic splines (RCS), threshold effect analysis, ubgroup analysis, Boruta algorithm, lasso algorithm, and receiver operating characteristics (ROC) to analyze the relationship between SHR and POAF incidence comprehensively.
results2112 patients undergoing CABG were included in this study, with a median age of 69 years (IQR: 62-76), of whom 1643 (77.79%) were male. Logistic regression results showed that the incidence of AF was significantly increased in patients in the highest third of the SHR group compared with the lowest third group (OR = 1.31, 95%CI = 1.03-1.67; P = 0.0275). SHR was an independent risk factor for the incidence of POAF (OR = 1.63, 95%CI = 1.19-2.23; P = 0.0023). At the same time, RCS analysis showed that SHR was positively and linearly correlated with the incidence of POAF in patients after cardiac surgery (P = 0.009, P for Nonliner = 0.848). Threshold effect analysis identified no significant threshold and further supported a linear relationship between SHR and POAF. In addition, SHR was double-screened by Boruta and Lasso algorithms, indicating that it was statistically and biologically significantly associated with AF after CABG.
conclusionSHR is significantly related to AF after CABG. As SHR increases, the risk of POAF increases. Incorporating SHR into post-CABG risk assessment enhances AF prediction, offering a valuable reference for clinical decision-making. It may also be a potential biomarker for studying pathological mechanisms in patients after cardiac surgery. In the future, combining multi-omics data with clinical intervention trials is necessary to verify its clinical application value further.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.